WallStreetZenWallStreetZen

NASDAQ: ACRS
Aclaris Therapeutics Inc Stock Ownership - Who owns Aclaris Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aclaris Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jesse Wayne HallChief Medical Officer2026-05-019,330$4.41
$41.15kSell
Braden Michael Leonard10% Owner2026-04-23300,000$4.53
$1.36MSell
Kevin BalthaserChief Financial Officer2026-03-01677$2.87
$1.94kSell
Neal WalkerCEO2026-02-0318,611$3.47
$64.58kSell
Kevin BalthaserChief Financial Officer2026-02-036,449$3.47
$22.38kSell
James LoeropChief Business Officer2026-02-035,937$3.47
$20.60kSell
Kevin BalthaserChief Financial Officer2026-02-014,984$3.51
$17.49kSell
James LoeropChief Business Officer2026-02-0110,686$3.51
$37.51kSell
James LoeropChief Business Officer2026-01-026,171$2.88
$17.77kSell
Kevin BalthaserChief Financial Officer2026-01-024,461$2.88
$12.85kSell

1 of 2

ACRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACRS insiders and whales buy or sell their stock.

ACRS Shareholders

What type of owners hold Aclaris Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Braden Michael Leonard30.25%42,243,975$185.87MInsider
Bml Capital Management LLC10.20%14,250,000$62.70MInstitution
Deep Track Capital LP6.69%9,345,000$41.12MInstitution
Fmr LLC6.18%8,637,727$38.01MInsider
Blackrock Inc5.30%7,407,065$32.59MInstitution
Ra Capital Management LP4.87%6,804,072$29.94MInstitution
Vivo Capital LLC4.77%6,666,666$29.33MInstitution
Vanguard Capital Management LLC3.70%5,167,469$22.74MInstitution
Frazier Life Sciences Management LP3.53%4,925,374$21.67MInstitution
Rock Springs Capital Management LP3.20%4,472,650$19.68MInstitution

1 of 3

ACRS vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACRS58.12%41.88%Net SellingNet Selling
CSTL86.18%13.82%Net SellingNet Selling
PSNL69.77%30.23%Net Buying
FLGT57.02%42.98%Net SellingNet Selling
LAB48.62%51.38%Net BuyingNet Selling
View Top Diagnostic & Research Stocks

Aclaris Therapeutics Stock Ownership FAQ

Who owns Aclaris Therapeutics?

Aclaris Therapeutics (NASDAQ: ACRS) is owned by 78.20% institutional shareholders, 56.35% Aclaris Therapeutics insiders, and 0.00% retail investors. Braden Michael Leonard is the largest individual Aclaris Therapeutics shareholder, owning 42.24M shares representing 30.25% of the company. Braden Michael Leonard's Aclaris Therapeutics shares are currently valued at $187.99M.

If you're new to stock investing, here's how to buy Aclaris Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.